InvestorsHub Logo
Followers 19
Posts 1107
Boards Moderated 0
Alias Born 03/27/2013

Re: None

Wednesday, 06/21/2017 9:44:44 AM

Wednesday, June 21, 2017 9:44:44 AM

Post# of 403773
May 10th - "This week Cellceutix anticipates enrolling the final subjects for the Brilacidin 42-day UP/UPS clinical study. "